OncoLink Cancer Treatment and Resources

Plasma Organochlorine Levels and the Risk of Breast Cancer

David J. Hunter, Susan E. Hankinson, Francine Laden, Graham A.Colditz, JoAnn E. Manson, Walter C.Willett, Frank E. Speizer, M
Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 1, 2001

Reviewers: John Han-Chih Chang, MD and Ken Blank, MD
Source: TheNew England Journal of Medicine -- October 30, 1997 -- Volume337, Number 18

Several correlative pieces of data indicate that environment playsan important role in the etiology ofbreastcancer. Included in this data is the fact that daughters of womenwho emigrate assume the breast cancer risk of the new country. Thequestion which has stymied researchers and physicians for years is--what in the environment causes breast cancer? One postulate is thatthe level of environmental estrogens such as organocholines inpesticides and industrial chemicals may cause breast cancer. The twomost commonly used organcholines are2,2,-bis(p-chlorylphenyl)-1,1,1-trichlorethane (DDT) and certainpolychlorinated biphenyls (PCBs).

In some animal models DDT was found to promote the growth ofbreast cancer. The metabolites of these two compounds haveestrogen-like activity and often linger in the human body-particularly the fat tissue - for long periods of time. A study inthe 1970s found that the large majority of nursing mothers haddetectable levels of PCB and DTT in their breast milk, even thoughDDT was banded from usage in the United States in 1975.

The association of these two substances with human breast canceris unclear. Several small studies indicate that women with breastcancer have a higher levels of PCB and DTT than controls. However,other studies found the opposite: that there was no associationbetween PCB and DTT levels and breast cancer. As reported in theOctober 30, 1997 New England Journal of Medicine, Hunter et al fromthe Harvard Medical School and Mount Sinai Hospital, New York,undertook a study and in which the blood samples of 240 breast cancerpatients were prospectively collected and measured for levels of bothDDE and PCBs. These levels The level of DDE was lower among breastcancer patients compared to controls. Additionally- and surprisingly- those women with the highest level of DDE and PCB had the lowestrisk of breast cancer. This report concludes that these DDT and PCBare not associated with beast cancer.

OncoLink I wish u knew...

Dr. O'Dwyer discusses pancreatic cancer, family history, screening and future research. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS